Eurointervention

Papers
(The TQCC of Eurointervention is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
TAVR under 70: is age just a number?229
International variation in modality and outcomes of left main revascularisation: does it really matter?126
Double-tap to treat paravalvular leak in high-risk annuli103
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity89
In search of the origin of the acronym TAVI79
Recanalisation of coronary chronic total occlusions76
Transcatheter left ventriculoplasty76
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis68
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis60
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study57
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry56
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement51
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure49
Defer-based non-stenting: a promising approach for STEMI48
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc46
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection46
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve44
Hybrid coronary revascularisation: the best or the worst of both worlds?43
The “road travelled”: reflections on the transformation of information exchange in a digital age42
   Atrial fibrillation and acute coronary syndrome 41
One-month DAPT after acute coronary syndrome: too short or not too short?40
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document39
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study39
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation38
Redo transcatheter mitral valve replacement in mitral annular calcification37
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study36
A novel robotic radiation shielding device for interventional cardiology procedures36
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes33
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis33
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons32
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial32
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD31
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial30
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation29
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement29
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the ra28
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation28
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty28
Cerebral embolic protection during transcatheter heart interventions27
Antithrombotic therapy for transcatheter structural heart intervention27
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation27
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry26
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study26
Percutaneous versus surgical transaxillary access for transcatheter aortic valve replacement: a propensity-matched analysis of the US experience26
A novel three-dimensional imaging approach to evaluate coronary access before transcatheter aortic valve-in-valve implantation25
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry25
Management of cardiogenic shock24
Early outcomes of transcatheter mitral valve replacement with the Tendyne system in severe mitral annular calcification24
Shifting focus in bifurcations.23
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial22
SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention22
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders22
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons21
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients21
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure21
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?20
Procedural and early outcomes of transcatheter edge-to-edge mitral valve repair in very elderly patients20
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 20
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome20
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation20
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions19
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography19
The patent foramen ovale does not spontaneously close in patients aged 6019
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome19
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons19
Robotics, imaging, and artificial intelligence in the catheterisation laboratory19
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair18
Targeting inflammation in atherosclerosis: overview, strategy and directions18
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias18
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation17
Stent underexpansion in the CRUNCH registry: worth cracking?17
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?17
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair17
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis17
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?17
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation17
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?17
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis17
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI17
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry16
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry16
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin16
Severely calcified coronary stenoses: a war or a battle?15
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease15
Letter: Caffeine and fractional flow reserve overestimation: a word of caution15
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography15
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis15
EuroIntervention: the 200th issue15
Reply: Spontaneous coronary artery dissection in France15
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies14
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons14
Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study13
Transcatheter aortic valve implantation in degenerated surgical aortic valves13
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials13
Device-related thrombus following left atrial appendage occlusion13
0.079166173934937